1.The Application of Vestibular Functional Test in the Diagnosis and Evaluation of Flight Illusion in Pilots
Zhanguo JIN ; Xianrong XU ; Yuhua LIU ; Yang ZHANG
Journal of Audiology and Speech Pathology 2004;0(06):-
0.05). ②Among 30 pilots with abnormal vestibular functions,19 were permanently grounded and 11 were permitted to return their flying station. 36 pilots returned to fly in 45 cases with normal vestibular functions. The permanently grounded rate had significant differences between the two groups with normal and abnormal vestibular functions. (P
2.Preliminary study on diplopore puncture of tympanum and intratympanic administration for management of acute secretory otitis media
Zulin TAN ; Yang ZHANG ; Xianrong XU ; Jidong ZHANG ; Zhanguo JIN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2010;(1):16-18
Objective:To evaluate the therapeutical effects of diplopore puncture of tympanum and intratympanic administration(DPTIA) on patients with acute secretory otitis media(ASOM).Method:One hundred and forty -one cases with ASOM were divided into two groups randomly,with 69 cases(80 ears) in group A(experimental group) and 72 cases(84 ears) in group B(control group).Group A was treated with DPTIA combined with medication, group B was treated with haplopore puncture of tympanum combined with medication. All patients accepted 1 to 3 courses of treament,and were observed during the period of treatment and 3 months after treatment.Result:The factors (including gender, age, side of ailing ear, course of disease, air-bone gap in the pure tone average,and acoustic immitance type in ailing ear) which may impact the prognosis were matched in two groups prior treatment(P>0.05). While there was a significant difference in the cure rate and the total effective rate respectively between two groups after treatment(P<0.05).No adverse reaction or complication was seen.Conclusion:DPTIA is a safe, reliable and effective way to manage patients with ASOM.
3.Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR
Zhanguo CHEN ; Wu ZHOU ; Zhongyong WANG ; Yalei JIN ; Zhihua TAO
Chinese Journal of Laboratory Medicine 2013;(3):217-221
Objective To analyze the suspicious results of serum HBV DNA by fluorescence quantitative PCR and develop appropriate countermeasures in order to improve the quality of detection of HBV DNA.Methods Blood samples of patients from the First Affiliated Hospital of Wenzhou Medical College from 2008 to 2011 were analyzed for HBV DNA by fluorescence quantitative PCR.1969 cases of suspicious results,judged by the rule of review the results of serum HBV DNA combined with the historical results,PCR amplification curve,HBV serum markers and clinical diagnosis,were analyzed and redetected by using of two different reagents,careHBV PCR Kit and careHBV PCR Kit V2,at the same time.The consistency and inconsistency ratio of the results were evaluated.Both the reasons of inconsistent and the undetected rates of careHBV PCR Kit were analyzed.The two reasons for the inconsistent results included the reagent related factors,e.g,showing no amplification curve caused by the false negative and abnormal low efficiency of amplification curve,and the non reagent related factors such as operating pollution and other sample factors.Results There were 115 154 blood samples were detected for HBV from 2008 to 2011 and 1969 samples (1.71%) with suspicious results were redetected.The consistency and inconsistency results were 1588 (80.65%) and 381 (19.35%),respectively.Every year from 2008 to 2011,the percentage of the inconsistent results caused by the reagent related factors were 18.87%,20.23%,51.33% and 59.57% respectively,which showed an increasing trend,and the percentage of inconsistent results caused by the nonreagent related factors were 81.13%,79.77%,48.67% and 40.43% respectively,which showed a declining trend year by year.The undetected rates of careHBV PCR Kit were 2.49%,4.08%,10.09% and 14.47% respectively,showing an increasing trend.Conclusions The redetection for the specimens with the suspicious results by using of different reagents can avoid the blind detection of HBV DNA and reduce the experimental error.All the clinical samples for quantitative HBV DNA including the mutations of HBV gene can be measured accurately and effectively,which is helpful to hepatitis B patients for antiviral therapy.
4.Effect of metformin on serum thyrotropin level in type 2 diabetic patients with subclinical hypothyroidism
Jiping NAN ; Fei GAO ; Qishan XU ; Zhanguo ZHAO ; Jin DONG
Chinese Journal of Primary Medicine and Pharmacy 2014;21(11):1619-1621
Objective To examine the effect of metformin on serum thyrotropin (TSH) level in diabetic patients with subclinical hypothyroidism (SCH).Methods The long-term effects of metformin on thyroid axis hormones were assessed in 55 diabetic patients with primary SCH who were untreated with L-T4(study group),as well as in 31 diabetic patients with normal thyroid function (control group).According to using metformin or not,patients of study group were divided into the metformin group (group 1,n =28),and the non-metformin group(group 2,n =27).Serum TSH levels were compared between baseline and follow-up in patients receiving metformin treatment.Results After 30 weeks of metformin administration,a significant TSH decrease(t =2.91,P < 0.05) was observed in group 1 [from(6.98 ± 1.92) to(2.44 ± 0.61) mIU/L].After stopping metformin therapy,the level of TSH at 52 weeks fol low-up was back to the baseline level [(6.99 ± 1.76) mIU/L,P > 0.05].There was no significant difference in TSH level between baseline and after 30 weeks follow-up in group 2[(6.01 ± 1.63) mIU/L vs(6.21 ± 1.71) mIU/L,P >0.05].At the end of 30 weeks follow-up,no significant differences were found in body mass index and thyroid func tion in both metformin group and non-metformin group.In control group,metformin administration for 30 weeks had no effect on TSH level(P > 0.05).Conclusion Metformin administration influences TSH without change of FT4 level in type 2 diabetic patients with primary SCH.
5.RP-HPLC fingerprint chromatogram of Baohe Pill
Zhanguo CHEN ; Hiaxia ZHAO ; Yanzi JIN ; Yubo CUI
Chinese Traditional Patent Medicine 1992;0(04):-
AIM: To provide a basis for appraising quality standard of Baohe Pill (Fructus Gataegi, Massa medicata fermentata, Rhizoma pinelliae, Pericapium citr reticulatae, Fructus forsythiae, Semen raphani, Fructus Mordei germinatus, Poria) inclusive of its RP-HPLC fingerprint chromatogram. METHODS: The chromatographic column was Kromasil C_ 18 column (4.6 mm?250 mm, i.d, 5-?m particle size). The mobile phase was 0.5% solution of ammonium dihydrogen phosphate (NH_4H_2PO_4), and the flow rate was 0.8 mL/min with UV detector at 214 nm. RESULTS: The RP-HPLC fingerprint chromatogram of Baohe Pill was established. In the experiment, for precision and repeatability, the RSD of each area of common peak was less than 3%. CONCLUSION: This method is simple and reliable.
6.Diagnostic Value of APRI Combined With FIB-4 for Significant Liver Fibrosis in Patients With Chronic Hepatitis B
Xiaohui MA ; Xin ZHANG ; Yun YOU ; Lili JIANG ; Jin ZHAO ; Zhanguo NIE
Chinese Journal of Gastroenterology 2017;22(9):544-547
Background:The diagnostic accuracy of APRI and FIB-4 for liver fibrosis in patients with chronic hepatitis B is nothigh,especially for significant liver fibrosis (F≥2). Noninvasive diagnosis for liver fibrosis has become a research hotspot;and the diagnostic value of APRI combined with FIB-4 is not clear. Aims:To investigate the diagnostic value ofAPRI combined with FIB-4 for significant liver fibrosis in patients with chronic hepatitis B. Methods:A total of 171patients with chronic hepatitis B from January 2011 to October 2016 at General Hospital of Xinjiang Military Region wereenrolled. Liver biochemical indices,routine blood test and liver biopsy pathology were performed. APRI and FIB-4 werecalculated,ROC curve was drawn,and cutoff value of APRI and FIB-4 for diagnosing significant liver fibrosis wasdetermined,and mode of APRI combined with FIB-4 for diagnosing significant liver fibrosis was established. Results:Withthe increase in degree of liver fibrosis,APRI and FIB-4 were gradually increased (P < 0. 05). Area under ROC curve(AUC)for APRI and FIB-4 were 0. 812 and 0. 770,respectively. The sensitivity of FIB-4 for diagnosing significant liverfibrosis was higher than that of APRI. Sensitivity,specificity,negative predictive value,positive predictive value,andaccuracy of APRI combined with FIB-4 for diagnosing significant liver fibrosis were superior to APRI or FIB-4 used alone;and the specificity,accuracy of mode 2 were superior to mode 1. Conclusions:APRI combined with FIB-4 can increasethe accuracy for diagnosing significant liver fibrosis.
7.Diagnosis, treatment and medical evaluation of head and neck tumors in aircrew.
Zulin TAN ; Xianrong XU ; Yang ZHANG ; Zhanguo JIN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(5):223-225
OBJECTIVE:
To sum up the experiences of diagnosis, treatment and medical evaluation of head and neck tumors in aircrew.
METHOD:
Sixty-seven cases of pilot patients with head and neck tumors in our hospital since September in 1979 to July in 2009 were retrospective analyzed in the study.
RESULT:
Among 44 aircrew with benign head and neck tumors there were 37 cases continued their flying jobs and 7 cases were permanently grounded; whereas in 23 aircrew with malignant tumors there were 6 cases qualified for flight and 17 patients unqualified.
CONCLUSION
Benign or malignant of the head and neck neoplasm in the pilots are not the exclusive basis for their medical assessment. Tumor nature, location, efficacy of treatment and the impact on the function of their body should be considered as making the flight medical evaluation for the aircrew with head and neck tumors. Early diagnosis and treatment of head and neck tumors in aircrew are very important for reducing the rate of grounded.
Adult
;
Aviation
;
Female
;
Head and Neck Neoplasms
;
diagnosis
;
epidemiology
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies
;
Young Adult
8.Diagnosis, treatment and medical evaluation of sinusitis and nasal polyp in aircrew.
Xianrong XU ; Yang ZHANG ; Xiaoli MA ; Zhanguo JIN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2009;23(5):194-200
OBJECTIVE:
To sum up the experiences of diagnosis, treatment and medical evaluation of sinusitis and nasal polyp in aircrew.
METHOD:
Ninety three aircrew with sinusitis and nasal polyp were included in the study.
RESULT:
There were 11 cases with acute sinusitis and 82 cases with chronic sinusitis and nasal polyp. Of the 82 cases, there were 46 cases in class I (including 39 cases with symptoms and signs on ground in Ia, 7 cases only with signs in Ib), 36 cases in class II (no symptoms on ground but with symptoms of secondary barotraumas in flight, including 14 cases with secondary barosinusitis in IIa, 13 cases with secondary barotrauma in IIb, 9 cases with secondary barosinusitis and barotrauma in IIc ). Of the 82 cases, there were 24 cases in 1 stage of type I, 38 cases in 2 stage of type I, 7 cases in 3 stage of type I, 2 cases in 1 stage of type II, 6 cases in 2 stage of type II, 3 cases in 3 stage of type II, 2 cases in type III. Eighty four cases continued their flying jobs and 9 cases were permanently grounded.
CONCLUSION
Flying safe can be endangered by sinusitis and nasal polyp alone or with its secondary barotraumas. Chronic sinusitis and nasal polyp complicated with barotraumas are important causation for medical grounding. The aircrew with sinusitis and nasal polyp will be allowed to continue their flying jobs only after getting well curative effect and normal gas pressures of ear and nasal sinus.
Adolescent
;
Adult
;
Barotrauma
;
complications
;
diagnosis
;
therapy
;
Chronic Disease
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nasal Polyps
;
complications
;
diagnosis
;
therapy
;
Sinusitis
;
complications
;
diagnosis
;
therapy
;
Young Adult
9.Characteristics of audiology and clinical genetics of a Chinese family with the DFNA5 genetic hearing loss.
Zhanguo JIN ; Jing CHENG ; Bing HAN ; Hongbo LI ; Yu LU ; Zhengyue LI ; Dongyi HAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(9):395-398
OBJECTIVE:
To analysis the characteristics of audiology and clinical genetics of a Chinese family with the DFNA5 genetic hearing loss in detail.
METHOD:
A detailed family history and clinical data were collected. The Chinese pedigree is an autosomal-dominant inherited hearing loss. The data of audiological examination about genetic characteristics was analysed. The relationship between the hearing-impaired of this family and age was contrasted.
RESULT:
This Chinese family spanned five generations and comprised 42 members. The mode of inheritance of the families should be autosomal dominant according to the pedigree. Pure-tone audiograms showed a so-called Z shape curve. The hearing loss is sensorineural, progressive and beginning at the high frequencies. The audiograms were fairly symmetric. Whole frequencies became involved with increasing age.
CONCLUSION
The Chinese family with the DFNA5 mutation was an autosomal dominant pedigree. In this family, non-syndromic symmetric hearing impairment was severest at the high frequencies early, and gradually accumulated all frequencies of hearing. A mutation in DFNA5 leads to a type of hearing loss that closely resembles the frequently observed age-related hearing impairment. It should take into account DFNA5 mutation which the audiogram of a genetic hearing impaired has the same feature.
Adolescent
;
Adult
;
Asian Continental Ancestry Group
;
genetics
;
Audiology
;
Child
;
Chromosome Disorders
;
genetics
;
Female
;
Hearing Loss
;
genetics
;
physiopathology
;
Hearing Tests
;
Humans
;
Male
;
Middle Aged
;
Pedigree
;
Receptors, Estrogen
;
genetics
;
Young Adult
10.Genetic and audiological characters of a Chinese family with non-syndromic hereditary hearing loss.
Zhanguo JIN ; Jing CHENG ; Yu LU ; Jianzhong LI ; Yi SUN ; Huijun YUAN ; Dongyi HAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2011;25(4):158-161
OBJECTIVE:
To investigate the phenotype and genetic characters of a Chinese family with an autosomal-dominant inherited high-frequency sensorineural hearing loss.
METHOD:
A Chinese pedigree associated with an autosomal-dominant inherited high-frequency sensorineural hearing loss was investigated. After obtaining informed consent from all study participants medical and audiological examination to rule out any syndromic hearing impairment. Application of microsatellite markers on DFNA 21 loci preliminary screening of 23 genes, data were analyzed by linkage analysis.
RESULT:
Proband of the family had been diagnosed with high-frequency sensorineural hearing loss. A Chinese family SX-H043 with non-syndromic hearing loss were ascertained. This Chinese family with late onset hearing impairment spanned four generations and comprised 43 members. The mode of inheritance of the families should be autosomal dominant according to the pedigree. Hearing impairment of affected members in family SX-H043 occurred 25 to 50 years descending audiograms. Whole frequencies became involved with increasing age.
CONCLUSION
A Chinese family with late-onset high-frequency sensorineural hearing loss were clinically studied. Positive sites were not found in the known deafness loci screening. The information should facilitate future gene scan and linkage analyses for novel relative genes contributing to high-frequency sensorineural hearing loss.
Adult
;
Age Factors
;
Female
;
Genetic Linkage
;
Hearing Loss, Sensorineural
;
congenital
;
genetics
;
physiopathology
;
Hearing Tests
;
Humans
;
Inheritance Patterns
;
Male
;
Microsatellite Repeats
;
Middle Aged
;
Pedigree
;
Phenotype